Capitalization and Title to Shares. (a) Company is authorized to issue 50,000,000 shares of Company Common Stock, of which 21,144,432 shares were issued and outstanding as of September 7, 2000. All of the issued and outstanding shares of Company Common Stock are duly authorized, validly issued, fully paid, nonassessable and free of pre-emptive rights.
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Genzyme Corp), Agreement and Plan of Merger (Geltex Pharmaceuticals Inc)
Capitalization and Title to Shares. (a) The Company is authorized to issue 50,000,000 shares of Company Common Stock, of which 21,144,432 17,364,401 shares were issued and outstanding as of September 7March 31, 20002001. All of the issued and outstanding shares of Company Common Stock are duly authorized, validly issued, fully paid, nonassessable and free of pre-emptive rights.
Appears in 1 contract
Capitalization and Title to Shares. (a) Company is authorized to issue 50,000,000 30,500,000 shares of Company Common Stock, of which 21,144,432 8,570,754 shares were issued and outstanding as of September 7August 9, 2000. All of the issued and outstanding shares of Company Company's Common Stock are duly authorized, validly issued, fully paid, nonassessable and free of pre-emptive rights.
Appears in 1 contract
Capitalization and Title to Shares. (a) The Company is authorized to issue 50,000,000 5,595,000 shares of Company Common Stock, of which 21,144,432 1,759,896 shares were issued and outstanding as of September 7August 3, 20002001. All of the issued and outstanding shares of Company Common Stock are duly authorized, validly issued, fully paid, nonassessable and free of pre-emptive rights. SECTION 2.3(a) of the Company Disclosure Schedule includes a true and complete list of all outstanding shares of Company Common Stock and Company Preferred Stock.
Appears in 1 contract
